The Investment Team at Ally Bridge Group is responsible for identifying, evaluating, and executing investment opportunities within the life sciences sector, including biopharma, biotech, medical devices, and private equity. Team members conduct in-depth research, financial analysis, and market assessments to support strategic investment decisions and manage the firm's diverse portfolio. They also work closely with stakeholders to ensure alignment with the firm's investment goals and risk management strategies.
Anna Yaeger
Portfolio Manager, New York
Barney Han
VP, Private Equity & Medical D...
Jiayun Zhou
Analyst
Peggie Lau
Senior Fund Accountant
Reese Yeh
Managing Director, Private Equ...
Steven Plachtyna
Research Analyst
Tian Sun
Research Analyst
Tinnie Chau
VP, Biopharma & Biotech Invest...
Whitney Hu
Associate
Zain Shekhani
Managing Director, Head Of Inv...
View all